Befar(SH:601678)2016-07-21 16:00Financial Performance - The company's operating revenue for the first half of 2016 was ¥2,064,225,345.59, a decrease of 16.73% compared to ¥2,479,088,490.21 in the same period last year[18]. - The net profit attributable to shareholders of the listed company was ¥48,017,190.82, down 80.58% from ¥247,248,448.54 in the previous year[18]. - The basic earnings per share decreased to ¥0.04, a decline of 80.95% compared to ¥0.21 in the same period last year[19]. - The weighted average return on net assets was 1.01%, a decrease of 4.47 percentage points from 5.48% in the previous year[19]. - The company's revenue from the chemical industry was approximately ¥2.05 billion, with a gross margin of 20.47%, a decrease of 3.37 percentage points year-on-year[36]. - Revenue from propylene oxide was approximately ¥906.63 million, with a gross margin of 14.85%, down 13.35 percentage points year-on-year[36]. - The company reported a significant decrease in net cash flow from investing activities compared to the same period last year, primarily due to reduced investments in financial products[34]. - The company reported a total revenue of 48,144,000.00 CNY for the first half of 2016, representing a 30.80% increase compared to the previous period[44]. Cash Flow and Liquidity - The net cash flow from operating activities was ¥453,763,525.01, a significant improvement from a negative cash flow of ¥35,558,476.93 in the previous year[18]. - The company's cash flow from operating activities for the first half of 2016 was ¥453,763,525.01, a significant improvement from a negative cash flow of ¥35,558,476.93 in the same period last year[33]. - The company's cash and cash equivalents increased to ¥516,186,112.86 from ¥448,008,578.55, reflecting a growth of approximately 15.2%[76]. - The total cash and cash equivalents at the end of the period stood at CNY 516,186,112.86, up from CNY 233,970,682.04 at the end of the previous year[93]. - The net increase in cash and cash equivalents for the period was CNY 68,177,534.31, contrasting with a decrease of CNY -311,144,524.13 in the same period last year[93]. Assets and Liabilities - The total assets at the end of the reporting period were ¥7,148,735,597.45, down 1.67% from ¥7,270,148,045.04 at the end of the previous year[18]. - The total current assets decreased from ¥1,399,955,416.29 to ¥1,314,930,097.62, a decline of approximately 6.1%[76]. - Total liabilities increased from ¥2,458,575,600.07 to ¥2,483,826,784.23, an increase of about 1.02%[78]. - Owner's equity decreased from ¥4,811,572,444.97 to ¥4,664,908,813.22, a decline of about 3.03%[79]. - The total owner's equity attributable to the parent company decreased from ¥4,754,444,261.09 to ¥4,663,352,501.19, a decline of approximately 1.91%[79]. Operational Highlights - The average selling price of liquid caustic soda was ¥466 per ton, showing a significant decline compared to the previous year[26]. - The sales volume of food-grade caustic soda increased by 25.55% year-on-year, totaling 40,512.89 tons, generating an economic benefit of ¥5.2275 million[27]. - The company successfully launched a 100,000-ton caustic soda production line, enhancing its product structure adjustment capabilities[27]. - The company's operating costs decreased compared to the same period last year, primarily due to a significant drop in the price of the main raw material, propylene[34]. Shareholder Information - The company distributed a total of 148,500,000 CNY in cash dividends to shareholders, amounting to 1.50 CNY per 10 shares, and increased its total share capital to 1,188,000,000 shares[48]. - The total number of shareholders was 54,257[65]. - The total number of shares held by the top ten shareholders represents a significant portion of the company's equity, indicating strong insider ownership[67]. - The total number of shares held by the top shareholder, Zhang Zhongzheng, increased by 20,790,000 to 124,740,000, representing 10.5% of the total shares[66]. Research and Development - The company's research and development expenditure decreased by 24.50% year-on-year, amounting to ¥3,527,078.33[33]. - Research and development expenditures remained relatively stable compared to the previous year[34]. - The company plans to focus on new product development and market expansion strategies to improve future performance[86]. Compliance and Governance - The financial report was approved by the board of directors on July 21, 2016, ensuring compliance with regulatory requirements[112]. - The company has confirmed that there are no significant doubts regarding its ability to continue as a going concern for the next 12 months[119]. - The company adheres to the accounting standards set by the Ministry of Finance and the China Securities Regulatory Commission, ensuring transparency in financial reporting[118]. Impairment and Losses - The company reported a 2518.32% increase in asset impairment losses for the first half of 2016 compared to the previous year, mainly due to increased impairment provisions from a subsidiary[30]. - The company experienced an increase in asset impairment losses to CNY 112,357,293.83, compared to CNY 4,291,205.43 in the previous period[84]. - The company recognizes impairment losses for equity investments when there is a severe or non-temporary decline in fair value[152]. Investment and Capital Structure - The company completed a capital reserve transfer to increase its total share capital from 990 million shares to 1.188 billion shares during the reporting period[20]. - The company recorded a significant increase in capital reserves, with a transfer of 198 million to capital stock during the current period[100]. - The total amount of capital increase from shareholders during the period was CNY 198,000,000.00, while the capital reserve decreased by the same amount[106].